Tranxenogen, Inc.
Records under this name other than patents Tranxenogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Tranxenogen, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,326,679 | Anticancer peptide compositions Lapsed on the fee record Ended Feb 5, 2020 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2020 | USPTO record |
| US 6,753,457 | Nuclear reprogramming using cytoplasmic extract Lapsed on the fee record Ended Jun 22, 2012 · USPTO record | Lapsed on the fee record | Ended Jun 22, 2012 | USPTO record |
| US 6,686,199 | Genetic manipulation of spermatogonia Lapsed on the fee record Ended Feb 3, 2012 · USPTO record | Lapsed on the fee record | Ended Feb 3, 2012 | USPTO record |